Literature DB >> 27352099

Breast cancer risk by the extent and type of atypical hyperplasia.

Amy C Degnim1, Daniel W Visscher2, Derek C Radisky3, Marlene H Frost4, Robert A Vierkant5, Ryan D Frank6, Stacey J Winham5, Celine M Vachon7, William D Dupont8, Lynn C Hartmann4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27352099      PMCID： PMC5577812          DOI： 10.1002/cncr.30151

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.

Authors:  Amy C Degnim; William D Dupont; Derek C Radisky; Robert A Vierkant; Ryan D Frank; Marlene H Frost; Stacey J Winham; Melinda E Sanders; Jeffrey R Smith; David L Page; Tanya L Hoskin; Celine M Vachon; Karthik Ghosh; Tina J Hieken; Lori A Denison; Jodi M Carter; Lynn C Hartmann; Daniel W Visscher
Journal:  Cancer       Date:  2016-06-28       Impact factor: 6.860

2.  Atypical hyperplasia of the breast--risk assessment and management options.

Authors:  Lynn C Hartmann; Amy C Degnim; Richard J Santen; William D Dupont; Karthik Ghosh
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

3.  Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.

Authors:  Laura C Collins; Sarah A Aroner; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2015-11-13       Impact factor: 6.860
  3 in total
  1 in total

Review 1.  The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.

Authors:  Edi Brogi
Journal:  Virchows Arch       Date:  2022-05-14       Impact factor: 4.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.